Published in Cell on November 04, 2005
Sialic acids in human health and disease. Trends Mol Med (2008) 2.61
Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003. Virology (2006) 1.90
Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol (2010) 1.80
Avoidance of protein fold disruption in natural virus recombinants. PLoS Pathog (2007) 1.62
Toward a broadly protective influenza vaccine. J Clin Invest (2008) 1.40
Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. J Virol (2009) 1.39
Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect (2007) 1.39
Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza. Virol J (2009) 1.33
Distinct glycan topology for avian and human sialopentasaccharide receptor analogues upon binding different hemagglutinins: a molecular dynamics perspective. J Mol Biol (2009) 1.27
The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J (2007) 1.24
Intraseasonal dynamics and dominant sequences in H3N2 influenza. PLoS One (2010) 1.20
Determinants of glycan receptor specificity of H2N2 influenza A virus hemagglutinin. PLoS One (2010) 1.20
Constraints to genetic exchange support gene coadaptation in a tripartite RNA virus. PLoS Pathog (2007) 1.07
Phylogenetic analysis reveals a correlation between the expansion of very virulent infectious bursal disease virus and reassortment of its genome segment B. J Virol (2006) 1.06
New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. J Virol (2013) 1.04
The receptor-binding domain of influenza virus hemagglutinin produced in Escherichia coli folds into its native, immunogenic structure. J Virol (2010) 1.03
Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol (2008) 1.02
Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic. Sci Rep (2013) 1.01
Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus. Clin Vaccine Immunol (2013) 0.95
The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants. Med Microbiol Immunol (2007) 0.91
Association and host selectivity in multi-host pathogens. PLoS One (2006) 0.89
Protection from Severe Influenza Virus Infections in Mice Carrying the Mx1 Influenza Virus Resistance Gene Strongly Depends on Genetic Background. J Virol (2015) 0.89
Cellular changes in blood indicate severe respiratory disease during influenza infections in mice. PLoS One (2014) 0.88
Comparative analysis between a low pathogenic and a high pathogenic influenza H5 hemagglutinin in cell entry. Virol J (2009) 0.88
Influenza H3N2 infection of the collaborative cross founder strains reveals highly divergent host responses and identifies a unique phenotype in CAST/EiJ mice. BMC Genomics (2016) 0.88
Glycan receptor specificity as a useful tool for characterization and surveillance of influenza A virus. Trends Microbiol (2014) 0.86
Evolution of the influenza a virus: some new advances. Evol Bioinform Online (2008) 0.84
Identification of critical residues of influenza neuraminidase in viral particle release. Virol J (2011) 0.83
The Effectiveness of Age-Specific Isolation Policies on Epidemics of Influenza A (H1N1) in a Large City in Central South China. PLoS One (2015) 0.81
Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice. Virol J (2012) 0.81
Comprehensive analysis of antibody recognition in convalescent humans from highly pathogenic avian influenza H5N1 infection. Nat Commun (2015) 0.80
Comparative serological assays for the study of h5 and h7 avian influenza viruses. Influenza Res Treat (2013) 0.80
Respiratory Mucosal Proteome Quantification in Human Influenza Infections. PLoS One (2016) 0.79
Use of praziquantel as an adjuvant enhances protection and Tc-17 responses to killed H5N1 virus vaccine in mice. PLoS One (2012) 0.78
Loss of CARD9-mediated innate activation attenuates severe influenza pneumonia without compromising host viral immunity. Sci Rep (2015) 0.78
Immunization with live virus vaccine protects highly susceptible DBA/2J mice from lethal influenza A H1N1 infection. Virol J (2012) 0.78
A novel approach to decrease sialic acid expression in cells by a C-3-modified N-acetylmannosamine. J Biol Chem (2014) 0.78
Virulence of H5N1 virus in mice attenuates after in vitro serial passages. Virol J (2011) 0.77
Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus. Sci Rep (2016) 0.76
An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice. Clin Vaccine Immunol (2013) 0.75
Harnessing DNA synthesis to develop rapid responses to emerging and pandemic pathogens. J Pathog (2011) 0.75
Polyphenolic glycosides isolated from Pogostemon cablin (Blanco) Benth. as novel influenza neuraminidase inhibitors. Chem Cent J (2016) 0.75
In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses. Adv Pharm Bull (2015) 0.75
Large-scale sequence analysis of avian influenza isolates. Science (2006) 9.87
Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med (2002) 9.47
Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol (2005) 7.36
Are we ready for pandemic influenza? Science (2003) 7.20
The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med (2006) 5.94
Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol (2005) 5.40
Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks. J Virol (2004) 5.17
Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002. Avian Pathol (2004) 5.08
Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol (2005) 5.04
Influenza A viruses of migrating wild aquatic birds in North America. Vector Borne Zoonotic Dis (2004) 4.89
Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine (2002) 4.45
Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci U S A (2009) 4.36
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother (2006) 4.02
Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J Virol (2007) 3.79
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A (2009) 3.70
Gain-of-function experiments on H7N9. Science (2013) 3.67
The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature (2013) 3.60
Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis (2006) 3.28
The influenza virus gene pool in a poultry market in South central china. Virology (2003) 3.25
Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother (2005) 3.04
Domestic ducks and H5N1 influenza epidemic, Thailand. Emerg Infect Dis (2006) 2.98
Influenza in migratory birds and evidence of limited intercontinental virus exchange. PLoS Pathog (2007) 2.94
Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol (2007) 2.77
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis (2006) 2.76
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis (2005) 2.72
Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A (2007) 2.63
Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J Gen Virol (2002) 2.63
Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J Virol (2005) 2.56
Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. J Clin Microbiol (2003) 2.55
H3N2 influenza virus transmission from swine to turkeys, United States. Emerg Infect Dis (2004) 2.53
The influenza virus enigma. Cell (2009) 2.48
Persistent host markers in pandemic and H5N1 influenza viruses. J Virol (2007) 2.42
Long-term evolution and transmission dynamics of swine influenza A virus. Nature (2011) 2.39
Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol (2007) 2.39
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
Influenza: emergence and control. J Virol (2004) 2.31
Pause on avian flu transmission research. Science (2012) 2.24
Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res (2002) 2.22
Adaptation of pandemic H1N1 influenza viruses in mice. J Virol (2010) 2.22
Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J Gen Virol (2005) 2.15
Retracted The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. Virus Res (2004) 2.15
Protection and compensation in the influenza virus-specific CD8+ T cell response. Proc Natl Acad Sci U S A (2003) 2.13
Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Proc Natl Acad Sci U S A (2005) 2.13
Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread. Proc Natl Acad Sci U S A (2008) 2.11
Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Respir Viruses (2009) 2.11
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants. Antiviral Res (2006) 2.11
Ducks: the "Trojan horses" of H5N1 influenza. Influenza Other Respir Viruses (2009) 2.10
Role of quail in the interspecies transmission of H9 influenza A viruses: molecular changes on HA that correspond to adaptation from ducks to chickens. J Virol (2003) 2.07
Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci U S A (2011) 2.04
Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother (2007) 2.03
Association of RIG-I with innate immunity of ducks to influenza. Proc Natl Acad Sci U S A (2010) 1.98
Rescue of influenza B virus from eight plasmids. Proc Natl Acad Sci U S A (2002) 1.92
Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis (2005) 1.83
Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens. J Virol (2004) 1.83
Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J Virol (2002) 1.82
Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets. PLoS Pathog (2010) 1.81
Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses. J Virol (2006) 1.74
Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants. J Virol (2004) 1.73
Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia. Virology (2005) 1.70
Does pandemic A/H1N1 virus have the potential to become more pathogenic? MBio (2010) 1.68
The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model. J Virol (2009) 1.68
Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol (2007) 1.65
H5N1 influenza viruses in Lao People's Democratic Republic. Emerg Infect Dis (2006) 1.64
Replication and transmission of influenza viruses in Japanese quail. Virology (2003) 1.64
Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrob Agents Chemother (2008) 1.63
Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets. J Infect Dis (2006) 1.62
Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001. J Virol (2003) 1.62
Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerg Infect Dis (2008) 1.59
Comment on "Seroevidence for H5N1 influenza infections in humans: meta-analysis". Science (2012) 1.58
Viral parkinsonism. Biochim Biophys Acta (2008) 1.57
Evolution and ecology of influenza A viruses. Curr Top Microbiol Immunol (2014) 1.57
Avian influenza viruses in Korean live poultry markets and their pathogenic potential. Virology (2005) 1.54
Coincident ruddy turnstone migration and horseshoe crab spawning creates an ecological 'hot spot' for influenza viruses. Proc Biol Sci (2010) 1.53
Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. J Gen Virol (2009) 1.52
Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antivir Ther (2007) 1.52
The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks. J Virol (2009) 1.50
Cooperation between the hemagglutinin of avian viruses and the matrix protein of human influenza A viruses. J Virol (2002) 1.49
Pandemic influenza as a current threat. Curr Top Microbiol Immunol (2009) 1.49
Interspecies transmission of an H7N3 influenza virus from wild birds to intensively reared domestic poultry in Italy. Virology (2004) 1.47
Continuing evolution of H9 influenza viruses in Korean poultry. Virology (2006) 1.45
Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets. PLoS Pathog (2010) 1.44
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrob Agents Chemother (2004) 1.41
Matrix gene of influenza a viruses isolated from wild aquatic birds: ecology and emergence of influenza a viruses. J Virol (2004) 1.41
Isolation and genetic characterization of H5N2 influenza viruses from pigs in Korea. J Virol (2009) 1.40
Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. J Virol (2009) 1.39
Drugs in development for influenza. Drugs (2010) 1.38
Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses. PLoS Pathog (2008) 1.37
Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J Gen Virol (2007) 1.37
Reconstruction of the 1918 influenza virus: unexpected rewards from the past. MBio (2012) 1.34
T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro. J Virol (2013) 1.34
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses. Antivir Ther (2005) 1.33
Novel reassortment of Eurasian avian-like and pandemic/2009 influenza viruses in swine: infectious potential for humans. J Virol (2011) 1.33
Role of terrestrial wild birds in ecology of influenza A virus (H5N1). Emerg Infect Dis (2007) 1.33
Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model. J Virol (2010) 1.33
Influenza A viruses in feral Canadian ducks: extensive reassortment in nature. J Gen Virol (2004) 1.32
Establishment and lineage replacement of H6 influenza viruses in domestic ducks in southern China. J Virol (2012) 1.32
Live bird markets of Bangladesh: H9N2 viruses and the near absence of highly pathogenic H5N1 influenza. PLoS One (2011) 1.32
Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks. J Virol (2008) 1.30
Receptor-binding profiles of H7 subtype influenza viruses in different host species. J Virol (2012) 1.29